| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 59.738 | 33.785 | 48.616 | 49.481 | 559 | 0 | 0 | 4.056 | 15.567 | 15.118 |
| Total Income - EUR | 59.738 | 33.785 | 48.616 | 49.481 | 559 | 0 | 0 | 4.056 | 15.567 | 15.118 |
| Total Expenses - EUR | 44.498 | 32.614 | 42.185 | 45.210 | 9.215 | 34.561 | 1.539 | 3.931 | 17.086 | 11.690 |
| Gross Profit/Loss - EUR | 15.240 | 1.170 | 6.430 | 4.271 | -8.656 | -34.561 | -1.539 | 125 | -1.520 | 3.428 |
| Net Profit/Loss - EUR | 13.448 | 491 | 4.972 | 3.763 | -8.672 | -34.561 | -1.539 | 3 | -1.669 | 2.880 |
| Employees | 4 | 4 | 2 | 2 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Calidanis Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 37.076 | 26.553 | 16.130 | 7.934 | 2.806 | 2.497 | 2.191 | 1.947 | 1.690 | 1.461 |
| Current Assets | 459 | 12.941 | 26.596 | 35.914 | 31.520 | 5.014 | 5.068 | 3.985 | 4.044 | 1.836 |
| Inventories | 0 | 361 | 759 | 587 | 291 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 171 | 3.505 | 1.696 | 417 | 611 | 4.991 | 5.044 | 811 | 2.975 | 1.810 |
| Cash | 288 | 9.075 | 24.141 | 34.910 | 30.618 | 23 | 23 | 3.174 | 1.069 | 26 |
| Shareholders Funds | 36.360 | 36.480 | 40.834 | 43.848 | 34.326 | -886 | -2.405 | -2.410 | -4.071 | -1.169 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 1.175 | 3.014 | 1.891 | 0 | 0 | 8.396 | 9.664 | 8.341 | 9.805 | 4.466 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Calidanis Med S.r.l.